S. Bambini

发表

Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870

Jeannette Adu-Bobie, Dan M. Granoff, Marzia Monica Giuliani, 2003, The Journal of experimental medicine.

Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives

S. Bambini, B. Brunelli, A. Biolchi, 2015, Expert review of vaccines.

Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales

M. Pizza, M. Comanducci, S. Bambini, 2009, Journal of Clinical Microbiology.

NarE: a novel ADP‐ribosyltransferase from Neisseria meningitidis

Jeannette Adu-Bobie, Rino Rappuoli, Mariagrazia Pizza, 2003, Molecular microbiology.

NadA, a Novel Vaccine Candidate of Neisseria meningitidis

R. Rappuoli, V. Masignani, B. Capecchi, 2002, The Journal of experimental medicine.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

R. Rappuoli, P. G. Lovaglio, D. Medini, 2013, The Lancet. Infectious diseases.

A universal vaccine for serogroup B meningococcus.

R. Rappuoli, V. Masignani, B. Capecchi, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.

R. Rappuoli, M. Pizza, L. DeTora, 2014, Vaccine.

NadA Diversity and Carriage in Neisseria meningitidis

R. Rappuoli, B. Capecchi, M. Pizza, 2004, Infection and Immunity.

Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine

M. Pizza, M. Comanducci, S. Bambini, 2010, Clinical and Vaccine Immunology.

Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.

R. Rappuoli, M. Gorla, M. Pizza, 2020, Vaccine.

Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.

R. Rappuoli, K. Jansen, L. Harrison, 2011, Vaccine.

Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1.

R. Rappuoli, D. Serruto, M. Pizza, 2011, Vaccine.

4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents

R. Rappuoli, M. Gorla, M. Pizza, 2020, Infectious Diseases and Therapy.

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis.

D. Medini, M. Pizza, S. Bambini, 2017, The Journal of infection.

Molecular and Serological Diversity of Neisseria meningitidis Carrier Strains Isolated from Italian Students Aged 14 to 22 Years

F. Ansaldi, G. Icardi, A. Orsi, 2014, Journal of Clinical Microbiology.

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine

M. Comanducci, S. Bambini, A. Muzzi, 2014, BMC Microbiology.

HadA is an atypical new multifunctional trimeric coiled‐coil adhesin of Haemophilus influenzae biogroup aegyptius, which promotes entry into host cells

R. Rappuoli, P. Cossart, V. Masignani, 2009, Cellular microbiology.

Characterisation of diverse sub-variants of the meningococcal factor H binding protein ( fHbp ) for their ability to bind fH , mediate serum resistance and induce bactericidal antibodies

R. Rappuoli, M. Pizza, M. Giuliani, 2013 .

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries

M. Comanducci, S. Bambini, M. Stella, 2016, PloS one.

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

R. Rappuoli, D. Medini, D. Serruto, 2010, Proceedings of the National Academy of Sciences.

Neisseria Adhesin A Variation and Revised Nomenclature Scheme

R. Rappuoli, V. Masignani, K. Jolley, 2014, Clinical and Vaccine Immunology.

A universal vaccine for serogroup B meningococcus.

R. Rappuoli, V. Masignani, B. Capecchi, 2006, Proceedings of the National Academy of Sciences of the United States of America.

The use of genomics in microbial vaccine development

Rino Rappuoli, R. Rappuoli, S. Bambini, 2009, Drug Discovery Today.

Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.

R. Rappuoli, M. Pizza, M. Comanducci, 2009, Vaccine.

Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies

R. Rappuoli, A. van der Ende, M. Pizza, 2010, Infection and Immunity.

Meningococcal diseases: From genomes to vaccines

R. Rappuoli, M. Pizza, L. Serino, 2006 .

An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands

R. Rappuoli, A. van der Ende, M. Pizza, 2013, PloS one.

Original Articles Forthcoming Papers in Cellular Microbiology Original Articles Vaccinia-induced Epidermal Growth Factor Receptor-mek Signalling and the Anti-apoptotic Protein F1l Synergize to Suppress Cell Death during Infection Thematic Reviews: Modelling Pathogenesis Resistance to Non-oxidative K

H. Augustin, F. Stadermann, C. Louis, 2022 .

Novel Vaccine Candidate of Neisseria meningitidis

R. Rappuoli, V. Masignani, B. Capecchi, 2002 .

Proteome analysis of Neisseria meningitidis serogroup A

M. Achtman, A. Scaloni, P. Martelli, 2004, Proteomics.

4CMenB journey to the 10-year anniversary and beyond

R. Rappuoli, M. Pizza, S. Bambini, 2024, Human vaccines & immunotherapeutics.